Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q100535275> ?p ?o ?g. }

Showing items 1 to 100 of ±105 with 100 items per page.

Q100535275 description "2020 nî lūn-bûn" @default.
Q100535275 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 14ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
Q100535275 description "2020年の論文" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年学术文章" @default.
Q100535275 description "2020年學術文章" @default.
Q100535275 description "2020年學術文章" @default.
Q100535275 description "2020年學術文章" @default.
Q100535275 description "2020年學術文章" @default.
Q100535275 description "2020年學術文章" @default.
Q100535275 description "2020년 논문" @default.
Q100535275 description "article científic" @default.
Q100535275 description "article scientific" @default.
Q100535275 description "article scientifique" @default.
Q100535275 description "articol științific" @default.
Q100535275 description "articolo scientifico" @default.
Q100535275 description "artigo científico" @default.
Q100535275 description "artigo científico" @default.
Q100535275 description "artigo científico" @default.
Q100535275 description "artikel ilmiah" @default.
Q100535275 description "artikull shkencor" @default.
Q100535275 description "artikulong pang-agham" @default.
Q100535275 description "artykuł naukowy" @default.
Q100535275 description "artículo científico publicado en 2020" @default.
Q100535275 description "artículu científicu" @default.
Q100535275 description "bilimsel makale" @default.
Q100535275 description "bài báo khoa học" @default.
Q100535275 description "naučni članak" @default.
Q100535275 description "scienca artikolo" @default.
Q100535275 description "scientific article published on 14 October 2020" @default.
Q100535275 description "scientific article published on 14 October 2020" @default.
Q100535275 description "scientific article published on 14 October 2020" @default.
Q100535275 description "teaduslik artikkel" @default.
Q100535275 description "tieteellinen artikkeli" @default.
Q100535275 description "tudományos cikk" @default.
Q100535275 description "vedecký článok" @default.
Q100535275 description "vetenskaplig artikel" @default.
Q100535275 description "videnskabelig artikel udgivet 14. oktober 2020" @default.
Q100535275 description "vitenskapelig artikkel" @default.
Q100535275 description "vitskapeleg artikkel" @default.
Q100535275 description "vědecký článek" @default.
Q100535275 description "wetenschappelijk artikel" @default.
Q100535275 description "wissenschaftlicher Artikel" @default.
Q100535275 description "επιστημονικό άρθρο" @default.
Q100535275 description "мақолаи илмӣ" @default.
Q100535275 description "наукова стаття, опублікована в жовтні 2020" @default.
Q100535275 description "научна статия" @default.
Q100535275 description "научная статья" @default.
Q100535275 description "научни чланак" @default.
Q100535275 description "научни чланак" @default.
Q100535275 description "מאמר מדעי" @default.
Q100535275 description "مقالة علمية نشرت في 14 أكتوبر 2020" @default.
Q100535275 description "১৪ অক্টোবর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
Q100535275 description "บทความทางวิทยาศาสตร์" @default.
Q100535275 description "სამეცნიერო სტატია" @default.
Q100535275 name "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 name "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 name "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 type Item @default.
Q100535275 label "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 label "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 label "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 prefLabel "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 prefLabel "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 prefLabel "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 P1433 Q100535275-8CB09C80-93E7-47B0-82C8-25D12A8DAE9F @default.
Q100535275 P1476 Q100535275-FDC7FF96-BCF1-45CF-8F68-12EACDCF77A3 @default.
Q100535275 P2093 Q100535275-017ED428-1EA9-4B2A-8993-DC2490197F32 @default.
Q100535275 P2093 Q100535275-2DA487D7-A1BF-45F9-9F22-00946A10DFE9 @default.
Q100535275 P2093 Q100535275-430642D6-D296-4EE4-A310-49828D984038 @default.
Q100535275 P2093 Q100535275-9B462B50-99EB-4E97-84DD-3FA8E37819D6 @default.
Q100535275 P2093 Q100535275-C4987980-E4FF-4EAF-87B5-BB32D89053CD @default.
Q100535275 P2093 Q100535275-D073AD45-1DB4-433A-87EA-37D9C341EF0E @default.
Q100535275 P2093 Q100535275-D2BC77B8-34E9-40C3-ABEA-28BC2CCC94C8 @default.
Q100535275 P304 Q100535275-243C5F94-936D-40E9-B817-99FA19207679 @default.
Q100535275 P31 Q100535275-02112DD9-94BB-4466-9115-0C0595DA06F0 @default.
Q100535275 P356 Q100535275-F8B3A6F3-FF8A-4A4D-BFF1-DBCC5A650C0F @default.
Q100535275 P433 Q100535275-6BE1995C-35C6-449C-BD3A-1432C574D750 @default.
Q100535275 P478 Q100535275-ED52B074-681E-4648-87D6-F78D2388C1DE @default.
Q100535275 P577 Q100535275-47846972-2DEB-4368-A57F-0774BAE7777F @default.
Q100535275 P698 Q100535275-B473E482-4C61-4264-808E-CF424E298D55 @default.
Q100535275 P932 Q100535275-C86C1B0F-1986-45AB-98D3-2A3509CA8D1D @default.
Q100535275 P356 S13613-020-00758-5 @default.
Q100535275 P698 33052490 @default.
Q100535275 P1433 Q18712109 @default.
Q100535275 P1476 "High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?" @default.
Q100535275 P2093 "Andrea Gallerani" @default.
Q100535275 P2093 "David De Bels" @default.
Q100535275 P2093 "Leonel Barreto Gutierrez" @default.
Q100535275 P2093 "Luc Kugener" @default.
Q100535275 P2093 "Patrick M Honore" @default.
Q100535275 P2093 "Rachid Attou" @default.
Q100535275 P2093 "Sebastien Redant" @default.
Q100535275 P304 "139" @default.
Q100535275 P31 Q13442814 @default.
Q100535275 P356 "10.1186/S13613-020-00758-5" @default.